DeutschNewstral
Article
bizjournals.com on 2015-07-27 13:34
Teva ends hostile bid for Mylan
Related news
Teva makes $40.1B unsolicited bid for MylanThe Salt Lake Tribune- FTeva set to lift Mylan bid to up to $43bnft.com
Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com
Mylan shareholders approve $34 billion hostile takeover bid for Perrigotriblive.com
Mylan rejects Teva Pharmaceutical's takeover bidpost-gazette.com- Teva accuses Mylan of suppressing bidThe Salt Lake Tribune
Mylan foundation to block Teva pharma’s hostile takeover bidtimesofisrael.com- Foundation triggers Mylan takeover defense seen as a roadblock for Teva bidtriblive.com
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bidReuters
Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bidThe Globe and Mail- Bloomberg: Teva to sweeten bid for Mylanbizjournals.com
Teva offers to buy Mylan for $40.1Bobserver-reporter.com- MMylan loses hostile bid for Perrigomarketwatch.com
Mylan Begins Hostile Bid for Perrigowsj.com- Mylan opens $27.14B hostile bid for PerrigoThe Salt Lake Tribune
Teva accuses Mylan of ‘desperate attempt’ to suppress bidThe Findlay Courier- Teva poised to take acquisition bid to Mylan shareholdersbizjournals.com
- Mylan skeptical of rumored Teva bid; hasn’t received offerobserver-reporter.com
- With Teva out of the way, stage set for Mylan to make new go at Perrigobizjournals.com